跳至主要内容
临床试验/NCT00592566
NCT00592566终止2 期

An Open Randomized Controlled Trial of Desmopressin, and Dexamethasone as Adjunctive Therapy in Patients With Pulmonary Hemorrhage Associated With Leptospirosis

Mahidol University1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2003年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
64
试验地点
1
主要终点
Survival

研究概览

简要总结

Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand.

Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients (> 14 years) with suspected severe leptospirosis
  • patients who presented with acute fever (oral temperature more than 38.00 C for <15 days) in the absence of an obvious focus of infection
  • In the opinion of the attending physician might have pulmonary hemorrhage (i.e. history of hemoptysis, and/ or bilateral nodular or air space infiltration).

排除标准

  • pregnant or breastfeeding
  • those with history of bleeding disorder
  • those who had underlying diseases such as chronic liver disease, diabetes mellitus
  • those who received diuretic or glucocorticoid

研究组 & 干预措施

2

Experimental

Dexamethasone treatment

干预措施: Dexamethasone, desmopressin (Drug)

3

Experimental

Desmopressin treatment

干预措施: Dexamethasone, desmopressin (Drug)

结局指标

主要结局

Survival

时间窗: during in hospital admission

次要结局

  • Days of mechanical ventilation(during hospital admission)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验